Skip to main content

Nuvalent, Inc.

NUVLDelisted Jul 15, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001861560

Nuvalent, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Nuvalent, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
4 insiders, $8.91M in total
Insiders trading
4
Net value
−$8.91M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Nuvalent, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Nuvalent, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Deerfield Management Company, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20263
Deerfield Mgmt L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Partners, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Flynn James EDirector, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20263
Deerfield Healthcare Innovations Fund, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Mgmt HIF, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Private Design Fund IV, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Deerfield Mgmt IV, L.P.Director, 10% Owner, Other: Director by Deputization0IndirectJul 17, 20262
Meyers Michael L.Director0Jul 15, 20262
Balcom AlexandraChief Financial Officer0Jul 15, 202614
Srivastava SapnaDirector0Jul 15, 20262
Oliger Christy J.Director0Jul 15, 20262
Squarer RonDirector0Jul 15, 20263
Turner Christopher DurantChief Medical Officer0Jul 15, 20262
Noci DarleneChief Development Officer0Jul 15, 202614
Lane BenjaminSee Remarks0Jul 15, 20262
Pelish Henry E.Chief Scientific Officer0Jul 15, 20268
Porter James RichardPresident and CEO0Jul 15, 20269
Miller Deborah AnnChief Legal Officer0Jul 15, 202612
Protopapas AnnaDirector0Jul 15, 20262
Bogle Grant C.Director0Jul 15, 20262
Wheeler CameronDirector0Jul 15, 20262
Shair MatthewDirector201,672IndirectNov 26, 20252
Pearlberg JosephDirector5,146Jun 20, 20250
Hack Andrew A. F.Director1,447,267IndirectDec 13, 20240
Conley EmilyDirector2,507Aug 27, 20240
Gilliland Dwight GaryDirector2,499Jun 14, 20240
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.10% Owner897,671Aug 3, 20210
Jackson Robert BowersDirector–Jul 30, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 4, 2023 (view filing)Oct 22 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−3.00K$45.88−$137.6K−100.0%0 after3 lots10b5-1
Oct 6, 2023 (view filing)Oct 42 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−20.0K$55.99−$1.12M−100.0%0 after2 lots10b5-1
Oct 6, 2023 (view filing)Oct 42 daysTurner Christopher DurantChief Medical OfficerSSaleClass A Common Stock−8.00K$54.04−$432.0K−35.5%14.5K after6 lots10b5-1
Oct 26, 2023 (view filing)Oct 242 daysShair MatthewDirectorSSaleClass A Common Stock−91.7K$50.70−$4.65M−4.7%1.85M after2 lots10b5-1
Nov 3, 2023 (view filing)Nov 12 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−3.00K$52.66−$158.0K−100.0%0 after3 lots10b5-1
Nov 30, 2023 (view filing)Nov 282 daysShair MatthewDirectorSSaleClass A Common Stock−9.15K$61.89−$566.3K−0.5%1.84M after2 lots10b5-1
Dec 20, 2023 (view filing)Dec 182 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−30.0K$75.82−$2.27M−100.0%0 after
Dec 20, 2023 (view filing)Dec 18-192 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−38.0K$75.71−$2.88M−100.0%0 after2 lots
Dec 20, 2023 (view filing)Dec 182 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−40.0K$75.82−$3.03M−100.0%0 after
Dec 20, 2023 (view filing)Dec 182 daysProtopapas AnnaDirectorSSaleClass A Common Stock−5.00K$75.67−$378.4K−100.0%0 after
Dec 28, 2023 (view filing)Dec 26-282 daysShair MatthewDirectorSSaleClass A Common Stock−119.2K$75.26−$8.97M−6.5%1.72M after5 lots10b5-1
Mar 19, 2024 (view filing)Mar 154 daysConley EmilyDirectorSSaleClass A Common Stock−13.3K$80.92−$1.08M−99.9%8 after5 lots10b5-1
Mar 25, 2024 (view filing)Mar 223 daysNoci DarleneChief Development OfficerSSaleClass A Common Stock−20.0K$77.51−$1.55M−37.5%33.3K after3 lots10b5-1
Mar 27, 2024 (view filing)Mar 252 daysShair MatthewDirectorSSaleClass A Common Stock−37.5K$76.77−$2.88M−2.2%1.69M after2 lots10b5-1
Mar 27, 2024 (view filing)Mar 252 daysShair MatthewDirectorSSaleClass A Common Stock−2.00K$76.77−$153.5K−0.8%238.5K after2 lots10b5-1
Mar 29, 2024 (view filing)Mar 281 dayMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−22.0K$75.20−$1.65M−39.8%33.3K after3 lots10b5-1
Mar 29, 2024 (view filing)Mar 272 daysHack Andrew A. F.DirectorSSaleClass A Common Stock−880.0K$72.77−$64.0M−24.6%2.70M after2 lots
Apr 3, 2024 (view filing)Apr 12 daysShair MatthewDirectorSSaleClass A Common Stock−37.5K$76.92−$2.88M−2.2%1.65M after2 lots10b5-1
Apr 5, 2024 (view filing)Apr 41 dayMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−3.00K$73.60−$220.8K−8.3%33.3K after4 lots10b5-1
Apr 10, 2024 (view filing)Apr 82 daysShair MatthewDirectorSSaleClass A Common Stock−37.5K$68.44−$2.57M−2.3%1.61M after3 lots10b5-1
Apr 17, 2024 (view filing)Apr 152 daysConley EmilyDirectorSSaleClass A Common Stock−5.00K$65.52−$327.6K−99.8%8 after2 lots10b5-1
Apr 17, 2024 (view filing)Apr 152 daysShair MatthewDirectorSSaleClass A Common Stock−37.5K$65.56−$2.46M−2.3%1.57M after2 lots10b5-1
Apr 24, 2024 (view filing)Apr 222 daysShair MatthewDirectorSSaleClass A Common Stock−37.5K$63.65−$2.39M−2.4%1.54M after3 lots10b5-1
May 1, 2024 (view filing)Apr 292 daysShair MatthewDirectorSSaleClass A Common Stock−37.5K$67.51−$2.53M−2.4%1.50M after3 lots10b5-1
May 1, 2024 (view filing)Apr 292 daysShair MatthewDirectorSSaleClass A Common Stock−2.00K$67.51−$135.0K−0.8%236.5K after3 lots10b5-1
May 3, 2024 (view filing)May 21 dayMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−3.00K$72.07−$216.2K−8.3%33.3K after3 lots10b5-1
May 8, 2024 (view filing)May 62 daysShair MatthewDirectorSSaleClass A Common Stock−37.5K$69.48−$2.61M−2.5%1.46M after2 lots10b5-1
May 15, 2024 (view filing)May 132 daysShair MatthewDirectorSSaleClass A Common Stock−37.5K$65.84−$2.47M−2.6%1.42M after3 lots10b5-1
May 17, 2024 (view filing)May 152 daysConley EmilyDirectorSSaleClass A Common Stock−5.00K$69.09−$345.4K−99.8%8 after10b5-1
May 29, 2024 (view filing)May 281 dayShair MatthewDirectorSSaleClass A Common Stock−2.00K$67.22−$134.4K−0.8%234.5K after3 lots10b5-1
Jun 7, 2024 (view filing)Jun 61 dayMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−8.00K$80.40−$643.2K−19.4%33.3K after9 lots10b5-1
Jun 18, 2024 (view filing)Jun 144 daysConley EmilyDirectorSSaleClass A Common Stock−5.00K$77.56−$387.8K−66.6%2.51K after2 lots10b5-1
Jun 26, 2024 (view filing)Jun 242 daysShair MatthewDirectorSSaleClass A Common Stock−2.00K$80.22−$160.4K−0.9%232.5K after3 lots10b5-1
Jul 2, 2024 (view filing)Jun 284 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−10.0K$75.43−$754.3K−23.1%33.3K after3 lots10b5-1
Jul 2, 2024 (view filing)Jul 11 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−5.00K$75.54−$377.7K−13.1%33.3K after2 lots10b5-1
Jul 10, 2024 (view filing)Jul 82 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−3.00K$73.23−$219.7K−8.3%33.3K after3 lots10b5-1
Jul 16, 2024 (view filing)Jul 124 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−6.00K$80.16−$481.0K−15.3%33.3K after10b5-1
Jul 16, 2024 (view filing)Jul 151 dayConley EmilyDirectorSSaleClass A Common Stock−5.00K$80.72−$403.6K−66.6%2.51K after4 lots10b5-1
Jul 31, 2024 (view filing)Jul 292 daysShair MatthewDirectorSSaleClass A Common Stock−2.00K$79.59−$159.2K−0.9%230.5K after4 lots10b5-1
Aug 2, 2024 (view filing)Jul 312 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−10.0K$79.51−$795.1K−23.1%33.3K after5 lots10b5-1
Aug 2, 2024 (view filing)Aug 11 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−5.00K$77.22−$386.1K−13.1%33.3K after5 lots10b5-1
Aug 9, 2024 (view filing)Aug 81 dayMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−3.00K$68.78−$206.3K−8.3%33.3K after5 lots10b5-1
Aug 27, 2024 (view filing)Aug 234 daysConley EmilyDirectorSSaleClass A Common Stock−3.33K$85.02−$283.5K−57.1%2.51K after10b5-1
Aug 27, 2024 (view filing)Aug 234 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−11.0K$85.04−$935.4K−24.8%33.3K after10b5-1
Aug 27, 2024 (view filing)Aug 234 daysPelish Henry E.Chief Scientific OfficerSSaleClass A Common Stock−10.5K$85.08−$893.3K−13.7%66.1K after10b5-1
Aug 27, 2024 (view filing)Aug 261 dayShair MatthewDirectorSSaleClass A Common Stock−2.00K$84.46−$168.9K−0.9%228.5K after3 lots10b5-1
Sep 4, 2024 (view filing)Aug 305 daysBalcom AlexandraChief Financial OfficerSSaleClass A Common Stock−10.0K$84.23−$842.3K−23.1%33.3K after3 lots10b5-1
Sep 4, 2024 (view filing)Sep 31 dayNoci DarleneChief Development OfficerSSaleClass A Common Stock−5.00K$84.43−$422.1K−13.1%33.3K after3 lots10b5-1
Sep 11, 2024 (view filing)Sep 92 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−3.00K$88.18−$264.5K−8.3%33.3K after4 lots10b5-1
Sep 18, 2024 (view filing)Sep 162 daysMiller Deborah AnnChief Legal OfficerSSaleClass A Common Stock−8.00K$96.47−$771.8K−19.4%33.3K after7 lots10b5-1